Bone grafts, bone graft extenders, substitutes and enhancers for acetabular reconstruction in revision total hip arthroplasty

Luca Pierannunzii, Luigi Zagra

Research output: Contribution to journalReview article

Abstract

Acetabular bone loss is a relevant concern for surgeons dealing with a failed total hip arthroplasty.Since the femoral head is no longer available, allografts represent the first choice for most reconstructive solutions, either as a structural buttress or impacted bone chips.Even though fresh-frozen bone is firmly recommended for structural grafts, freeze-dried and/or irradiated bone may be used alternatively for impaction grafting. Indeed, there are some papers on freeze-dried or irradiated bone impaction grafting, but their number is limited, as is the number of cases.Xenografts do not represent a viable option based on the poor available evidence but bioactive bioceramics such as hydroxyapatite and biphasic calcium phosphates are suitable bone graft extenders or even substitutes for acetabular impaction grafting.Bone-marrow-derived mesenchymal stem cells and demineralised bone matrix seem to act as reliable bone graft enhancers, i.e. adjuvant therapies able to improve the biological performance of standard bone grafts or substitutes. Among these therapies, platelet-rich plasma and bone morphogenetic proteins need to be investigated further before any recommendations can be made. Cite this article:EFORT Open Rev2016;1:431-439. DOI:10.1302/2058-5241.160025.

Original languageEnglish
Pages (from-to)431-439
Number of pages9
JournalEFORT Open Reviews
Volume1
Issue number12
DOIs
Publication statusPublished - Mar 2017

Fingerprint

Arthroplasty
Hip
Transplants
Bone and Bones
Bone Morphogenetic Proteins
Bone Matrix
Platelet-Rich Plasma
Bone Transplantation
Durapatite
Thigh
Mesenchymal Stromal Cells
Heterografts
Allografts
Bone Marrow
Therapeutics

Cite this

Bone grafts, bone graft extenders, substitutes and enhancers for acetabular reconstruction in revision total hip arthroplasty. / Pierannunzii, Luca; Zagra, Luigi.

In: EFORT Open Reviews, Vol. 1, No. 12, 03.2017, p. 431-439.

Research output: Contribution to journalReview article

@article{4aacdc381c4d4b3c857ba871457f5721,
title = "Bone grafts, bone graft extenders, substitutes and enhancers for acetabular reconstruction in revision total hip arthroplasty",
abstract = "Acetabular bone loss is a relevant concern for surgeons dealing with a failed total hip arthroplasty.Since the femoral head is no longer available, allografts represent the first choice for most reconstructive solutions, either as a structural buttress or impacted bone chips.Even though fresh-frozen bone is firmly recommended for structural grafts, freeze-dried and/or irradiated bone may be used alternatively for impaction grafting. Indeed, there are some papers on freeze-dried or irradiated bone impaction grafting, but their number is limited, as is the number of cases.Xenografts do not represent a viable option based on the poor available evidence but bioactive bioceramics such as hydroxyapatite and biphasic calcium phosphates are suitable bone graft extenders or even substitutes for acetabular impaction grafting.Bone-marrow-derived mesenchymal stem cells and demineralised bone matrix seem to act as reliable bone graft enhancers, i.e. adjuvant therapies able to improve the biological performance of standard bone grafts or substitutes. Among these therapies, platelet-rich plasma and bone morphogenetic proteins need to be investigated further before any recommendations can be made. Cite this article:EFORT Open Rev2016;1:431-439. DOI:10.1302/2058-5241.160025.",
author = "Luca Pierannunzii and Luigi Zagra",
year = "2017",
month = "3",
doi = "10.1302/2058-5241.160025",
language = "English",
volume = "1",
pages = "431--439",
journal = "EFORT Open Reviews",
issn = "2058-5241",
publisher = "British Editorial Society of Bone and Joint Surgery",
number = "12",

}

TY - JOUR

T1 - Bone grafts, bone graft extenders, substitutes and enhancers for acetabular reconstruction in revision total hip arthroplasty

AU - Pierannunzii, Luca

AU - Zagra, Luigi

PY - 2017/3

Y1 - 2017/3

N2 - Acetabular bone loss is a relevant concern for surgeons dealing with a failed total hip arthroplasty.Since the femoral head is no longer available, allografts represent the first choice for most reconstructive solutions, either as a structural buttress or impacted bone chips.Even though fresh-frozen bone is firmly recommended for structural grafts, freeze-dried and/or irradiated bone may be used alternatively for impaction grafting. Indeed, there are some papers on freeze-dried or irradiated bone impaction grafting, but their number is limited, as is the number of cases.Xenografts do not represent a viable option based on the poor available evidence but bioactive bioceramics such as hydroxyapatite and biphasic calcium phosphates are suitable bone graft extenders or even substitutes for acetabular impaction grafting.Bone-marrow-derived mesenchymal stem cells and demineralised bone matrix seem to act as reliable bone graft enhancers, i.e. adjuvant therapies able to improve the biological performance of standard bone grafts or substitutes. Among these therapies, platelet-rich plasma and bone morphogenetic proteins need to be investigated further before any recommendations can be made. Cite this article:EFORT Open Rev2016;1:431-439. DOI:10.1302/2058-5241.160025.

AB - Acetabular bone loss is a relevant concern for surgeons dealing with a failed total hip arthroplasty.Since the femoral head is no longer available, allografts represent the first choice for most reconstructive solutions, either as a structural buttress or impacted bone chips.Even though fresh-frozen bone is firmly recommended for structural grafts, freeze-dried and/or irradiated bone may be used alternatively for impaction grafting. Indeed, there are some papers on freeze-dried or irradiated bone impaction grafting, but their number is limited, as is the number of cases.Xenografts do not represent a viable option based on the poor available evidence but bioactive bioceramics such as hydroxyapatite and biphasic calcium phosphates are suitable bone graft extenders or even substitutes for acetabular impaction grafting.Bone-marrow-derived mesenchymal stem cells and demineralised bone matrix seem to act as reliable bone graft enhancers, i.e. adjuvant therapies able to improve the biological performance of standard bone grafts or substitutes. Among these therapies, platelet-rich plasma and bone morphogenetic proteins need to be investigated further before any recommendations can be made. Cite this article:EFORT Open Rev2016;1:431-439. DOI:10.1302/2058-5241.160025.

U2 - 10.1302/2058-5241.160025

DO - 10.1302/2058-5241.160025

M3 - Review article

VL - 1

SP - 431

EP - 439

JO - EFORT Open Reviews

JF - EFORT Open Reviews

SN - 2058-5241

IS - 12

ER -